
Javier A. Villafuerte Gálvez
@jvg_gimd
Gastroenterologist @BIDMC_GI & @harvardmed |🇵🇪 MD @CayetanoHeredia | Interests: C.difficile, celiac disease, IBD, H.pylori, onco-GI
ID: 227741098
17-12-2010 17:41:08
3,3K Tweet
1,1K Followers
1,1K Following

Ben Click David Fudman, MD Amelie Therrien MD MSc Javier A. Villafuerte Gálvez Aline Charabaty, MD, FACG, AGAF #MondayNightIBD AbbVie JanssenUS Takeda IBDJournal & CC360 John Damianos, M.D. John Ding MD PhD Eugene Yen Jon Moses, MD Kofi Clarke MD Michael J Rosen, MD, MSCI Benjamin Lebwohl Ritu Verma Center for Celiac Research and Treatment BIDMC_GI Peter Bossuyt Robert Battat MD Benjamin Clement, MD AJG - The American Journal of Gastroenterology Sahil Khanna, MBBS, MS, FACG, AGAF (he/him) Less expensive, able to taper dose when needed for maintenance.

Aline Charabaty, MD, FACG, AGAF Javier A. Villafuerte Gálvez #MondayNightIBD AbbVie JanssenUS Takeda IBDJournal & CC360 Darrell Pardi John Damianos, M.D. John Ding MD PhD Eugene Yen Jon Moses, MD Kofi Clarke MD Michael J Rosen, MD, MSCI Benjamin Lebwohl Ritu Verma Center for Celiac Research and Treatment BIDMC_GI Amelie Therrien MD MSc Peter Bossuyt Benjamin Clement, MD AJG - The American Journal of Gastroenterology Sahil Khanna, MBBS, MS, FACG, AGAF (he/him) Not much to add beyond that it seems to work! The moa still needs some deciphering. Not sure if mentioned , but “refractory MC” often responds to budesonide AND removal of inciting drug (PPI, SSRI ( although conflicting data, anecdotally has worked for my pts))

Javier A. Villafuerte Gálvez Eugene Yen Aline Charabaty, MD, FACG, AGAF Amelie Therrien MD MSc #MondayNightIBD AbbVie JanssenUS Takeda IBDJournal & CC360 Darrell Pardi John Damianos, M.D. John Ding MD PhD Jon Moses, MD Kofi Clarke MD Michael J Rosen, MD, MSCI Benjamin Lebwohl Ritu Verma Center for Celiac Research and Treatment BIDMC_GI Peter Bossuyt Robert Battat MD Benjamin Clement, MD AJG - The American Journal of Gastroenterology Sahil Khanna, MBBS, MS, FACG, AGAF (he/him) Nisha Loganantharaj Jonny Blackwell Jami Kinnucan, MD, FACG, AGAF, FCCF Peter Higgins As Eugene Yen notes - I’ve had imuran work As Aline Charabaty, MD, FACG, AGAF notes - I only use it if I have insurances issues. I do have one patient refractory to IFX, VDZ, finally capture remission on TOF But this is very atypical

carlos rettally Aline Charabaty, MD, FACG, AGAF Shrinivas Bishu Amelie Therrien MD MSc Javier A. Villafuerte Gálvez #MondayNightIBD AbbVie JanssenUS Takeda IBDJournal & CC360 Darrell Pardi John Damianos, M.D. John Ding MD PhD Jon Moses, MD Kofi Clarke MD Michael J Rosen, MD, MSCI Benjamin Lebwohl Ritu Verma Center for Celiac Research and Treatment BIDMC_GI Peter Bossuyt Robert Battat MD Benjamin Clement, MD AJG - The American Journal of Gastroenterology Sahil Khanna, MBBS, MS, FACG, AGAF (he/him) Nisha Loganantharaj Jonny Blackwell Jami Kinnucan, MD, FACG, AGAF, FCCF Peter Higgins Vicent Hernandez Beatriz Gros ignacio catalan Patriciakaazan Joyce Mak Sang Hyoung Park Lumír Kunovský Jan Král 𝙱𝚎𝚗 𝙳𝚒𝚜𝚗𝚎𝚢 Keith Siau N=12. I think this works as well as loperamide (both reasonable for mild disease). I also never give 9 tabs of bismuth daily.

Eugene Yen Aline Charabaty, MD, FACG, AGAF Shrinivas Bishu Amelie Therrien MD MSc Javier A. Villafuerte Gálvez #MondayNightIBD AbbVie JanssenUS Takeda IBDJournal & CC360 Darrell Pardi John Damianos, M.D. John Ding MD PhD Jon Moses, MD Kofi Clarke MD Michael J Rosen, MD, MSCI Benjamin Lebwohl Ritu Verma Center for Celiac Research and Treatment BIDMC_GI Peter Bossuyt Robert Battat MD Benjamin Clement, MD AJG - The American Journal of Gastroenterology Sahil Khanna, MBBS, MS, FACG, AGAF (he/him) Nisha Loganantharaj Jonny Blackwell Jami Kinnucan, MD, FACG, AGAF, FCCF Peter Higgins Vicent Hernandez Beatriz Gros ignacio catalan Patriciakaazan Joyce Mak Sang Hyoung Park Lumír Kunovský Jan Král 𝙱𝚎𝚗 𝙳𝚒𝚜𝚗𝚎𝚢 Keith Siau Agree with both Given significant weight loss, unlikely to work but worthwhile to have it (as well as Loperamide) as part of the convo

Shrinivas Bishu Javier A. Villafuerte Gálvez Aline Charabaty, MD, FACG, AGAF Amelie Therrien MD MSc #MondayNightIBD AbbVie JanssenUS Takeda IBDJournal & CC360 Darrell Pardi John Damianos, M.D. John Ding MD PhD Jon Moses, MD Kofi Clarke MD Michael J Rosen, MD, MSCI Benjamin Lebwohl Ritu Verma Center for Celiac Research and Treatment BIDMC_GI Peter Bossuyt Robert Battat MD Benjamin Clement, MD AJG - The American Journal of Gastroenterology Sahil Khanna, MBBS, MS, FACG, AGAF (he/him) Nisha Loganantharaj Jonny Blackwell Jami Kinnucan, MD, FACG, AGAF, FCCF Peter Higgins I sincerely don’t think that biologics are safer than low dose Aza. Perhaps more effective but access is not my only reason for using im. Maybe I’m just old.

Eugene Yen Shrinivas Bishu Javier A. Villafuerte Gálvez Amelie Therrien MD MSc #MondayNightIBD AbbVie JanssenUS Takeda IBDJournal & CC360 Darrell Pardi John Damianos, M.D. John Ding MD PhD Jon Moses, MD Kofi Clarke MD Michael J Rosen, MD, MSCI Benjamin Lebwohl Ritu Verma Center for Celiac Research and Treatment BIDMC_GI Peter Bossuyt Robert Battat MD Benjamin Clement, MD AJG - The American Journal of Gastroenterology Sahil Khanna, MBBS, MS, FACG, AGAF (he/him) Nisha Loganantharaj Jonny Blackwell Jami Kinnucan, MD, FACG, AGAF, FCCF Peter Higgins Not old Eugene Yen ! Simply vintage cool 😎😎😎

𝙱𝚎𝚗 𝙳𝚒𝚜𝚗𝚎𝚢 Beatriz Gros Aline Charabaty, MD, FACG, AGAF Shrinivas Bishu Amelie Therrien MD MSc Javier A. Villafuerte Gálvez #MondayNightIBD AbbVie JanssenUS Takeda IBDJournal & CC360 Darrell Pardi John Damianos, M.D. John Ding MD PhD Eugene Yen Jon Moses, MD Kofi Clarke MD Michael J Rosen, MD, MSCI Benjamin Lebwohl Ritu Verma Center for Celiac Research and Treatment BIDMC_GI Peter Bossuyt Robert Battat MD Benjamin Clement, MD AJG - The American Journal of Gastroenterology Sahil Khanna, MBBS, MS, FACG, AGAF (he/him) Nisha Loganantharaj Jonny Blackwell Jami Kinnucan, MD, FACG, AGAF, FCCF Peter Higgins Vicent Hernandez ignacio catalan Patriciakaazan Joyce Mak Sang Hyoung Park Lumír Kunovský Jan Král Keith Siau 𝗗𝗿 𝗔𝗷𝗮𝘆 𝗠 𝗩𝗲𝗿𝗺𝗮 Jonathan Segal Prof Richard Pollok Even with low dose budesonide patients can experience AEs. Thiopurines, Antitnfs & vedolizumab work for some, moving towards Jaks and Uste for a select few. Collagenous colitis seems more difficult to treat than lymphocytic - need a guideline 😉BSG Crohn's & Colitis UK

Jonathan Segal 𝙱𝚎𝚗 𝙳𝚒𝚜𝚗𝚎𝚢 Beatriz Gros Aline Charabaty, MD, FACG, AGAF Shrinivas Bishu Amelie Therrien MD MSc Javier A. Villafuerte Gálvez #MondayNightIBD AbbVie JanssenUS Takeda IBDJournal & CC360 Darrell Pardi John Damianos, M.D. John Ding MD PhD Eugene Yen Jon Moses, MD Kofi Clarke MD Michael J Rosen, MD, MSCI Benjamin Lebwohl Ritu Verma Center for Celiac Research and Treatment BIDMC_GI Peter Bossuyt Robert Battat MD Benjamin Clement, MD AJG - The American Journal of Gastroenterology Sahil Khanna, MBBS, MS, FACG, AGAF (he/him) Nisha Loganantharaj Jonny Blackwell Jami Kinnucan, MD, FACG, AGAF, FCCF Peter Higgins Vicent Hernandez ignacio catalan Patriciakaazan Joyce Mak Sang Hyoung Park Lumír Kunovský Jan Král Keith Siau 𝗗𝗿 𝗔𝗷𝗮𝘆 𝗠 𝗩𝗲𝗿𝗺𝗮 Prof Richard Pollok Aditi Kumar Matthew Brookes No RCTs with advanced therapies for Microscopic colitis? This would be a great area for testing in a platform trial. BSG Crohn's & Colitis UK National Institute for Health and Care Research

DrShahidaDin Jonathan Segal 𝙱𝚎𝚗 𝙳𝚒𝚜𝚗𝚎𝚢 Beatriz Gros Aline Charabaty, MD, FACG, AGAF Shrinivas Bishu Amelie Therrien MD MSc Javier A. Villafuerte Gálvez #MondayNightIBD AbbVie JanssenUS Takeda IBDJournal & CC360 Darrell Pardi John Damianos, M.D. John Ding MD PhD Eugene Yen Jon Moses, MD Kofi Clarke MD Michael J Rosen, MD, MSCI Benjamin Lebwohl Ritu Verma Center for Celiac Research and Treatment BIDMC_GI Peter Bossuyt Robert Battat MD Benjamin Clement, MD AJG - The American Journal of Gastroenterology Sahil Khanna, MBBS, MS, FACG, AGAF (he/him) Nisha Loganantharaj Jonny Blackwell Jami Kinnucan, MD, FACG, AGAF, FCCF Peter Higgins Vicent Hernandez Patriciakaazan Joyce Mak Sang Hyoung Park Lumír Kunovský Jan Král Keith Siau 𝗗𝗿 𝗔𝗷𝗮𝘆 𝗠 𝗩𝗲𝗿𝗺𝗮 Prof Richard Pollok Aditi Kumar Matthew Brookes BSG Crohn's & Colitis UK National Institute for Health and Care Research Bram Verstockt JAKi?


#MondayNightIBD Javier A. Villafuerte Gálvez Darrell Pardi David Fudman, MD Shrinivas Bishu John Damianos, M.D. carlos rettally Joshua M. Steinberg, MD Ben Click Yamile Zabana DrShahidaDin 𝙱𝚎𝚗 𝙳𝚒𝚜𝚗𝚎𝚢 #IBDAlgorithm #MondayNightIBD 🎯Refractory #celiac disease & #microscopic_Colitis? Aline Charabaty, MD, FACG, AGAF w/guest Javier A. Villafuerte Gálvez😍 🧩Differentiate b/w txt non-response & confounding factors (precipitating 💊, co-existing diseases) 🧩Confirm Gluten-free🍲 🧩Repeat🔦may be warranted





#MondayNightIBD Aline Charabaty, MD, FACG, AGAF Eli Lilly and Company Joseph Sleiman, MD, FACP Shrinivas Bishu Parakkal Deepak MD, MS, FACG Amar S. Naik, MD Joshua M. Steinberg, MD Waseem Ahmed Jana G Hashash, MD, MSc Jason Schairer 28F ileal #Crohns At dx CLN: deep ileal ulcers, SES-CD 7 CRP 10 mg/L, FCP 650 Started on IFX, ⬆️ to 10mg/kg q4wks to reach clinical remission 🔦Repeat CLN at 1 yr: improved with few round ulcers, SES-CD 3. FCP 350. IFX level 15, no ATI What’s next in your #T2T management?

Does PPI change the serum and urine calcium levels? 🤔 Come check out this 🔥poster (S2299) by our ⭐️member Tulio Correa, MD, present today at #ACG2024 #GITwitter ACG Javier A. Villafuerte Gálvez BIDMC_GI




Chronic pancreatitis pain and disorders of gut brain interaction likely share common ascending/descending pathways. Time for a unified approach among neuromotilists and pancreatilogists? American Pancreatic Association ANMS American Gastroenterological Association (AGA) ACG Brian Jacobson Nneka N. Ufere, MD MSCE
